Table 3.
Predictors for mortality within 6 moa | History of pre-TIPS HE | No history of pre-TIPS HE | ||||||
n | OR | P | 95% CI | n | OR | P | 95% CI | |
Age ≥65 yr | 126 | 1.78 | 0.266 | 0.64–4.94 | 76 | 1.46 | 0.527 | 0.45–4.77 |
Male vs female | 126 | 0.54 | 0.197 | 0.21–1.38 | 76 | 1.06 | 0.923 | 0.32–3.55 |
Stent type: traditional vs controlled expansion | 126 | 1.95 | 0.262 | 0.61–6.24 | 76 | 0.88 | 0.860 | 0.21–3.65 |
MELD score | 125 | 1.12 | 0.001 | 1.05–1.21 | 75 | 1.04 | 0.411 | 0.95–1.14 |
MELD-Na score | 125 | 1.13 | 0.002 | 1.05–1.21 | 75 | 1.04 | 0.323 | 0.96–1.14 |
Child-Pugh score | 125 | 1.56 | 0.010 | 1.11–2.16 | 74 | 1.99 | 0.080 | 0.92–4.32 |
≥1 admission for HE within 6 mo pre-TIPS | 126 | 2.40 | 0.117 | 0.80–7.16 | 0 | — | — | — |
≥1 ICU admission for HE within 6 mo pre-TIPS | 126 | 1.74 | 0.518 | 0.33–9.26 | 0 | — | — | — |
PV pressure | 121 | 0.99 | 0.725 | 0.91–1.07 | 75 | 1.02 | 0.790 | 0.91–1.14 |
RA pressure | 120 | 0.98 | 0.699 | 0.88–1.09 | 74 | 1.04 | 0.525 | 0.92–1.18 |
PSPG | 124 | 0.99 | 0.812 | 0.90–1.08 | 75 | 0.94 | 0.371 | 0.83–1.07 |
AST | 126 | 0.99 | 0.628 | 0.97–1.02 | 75 | 1.00 | 0.295 | 1.00–1.01 |
ALT | 126 | 1.00 | 0.8876 | 0.97–1.03 | 75 | 1.01 | 0.262 | 1.00–1.02 |
Sodium | 126 | 0.96 | 0.389 | 0.87–1.06 | 76 | 0.96 | 0.534 | 0.86–1.08 |
Albumin | 126 | 1.44 | 0.275 | 0.75–2.76 | 73 | 0.59 | 0.313 | 0.21–1.64 |
Bilirubin (total) | 126 | 1.12 | 0.008 | 1.03–1.23 | 75 | 1.11 | 0.735 | 0.60–2.08 |
Creatinine | 126 | 1.18 | 0.481 | 0.75–1.86 | 76 | 1.29 | 0.254 | 0.83–2.01 |
Blood urea nitrogen | 122 | 1.02 | 0.052 | 1.00–1.05 | 74 | 1.02 | 0.348 | 0.98–1.05 |
Body weight | 121 | 0.99 | 0.054 | 0.98–1.00 | 75 | 0.99 | 0.277 | 0.98–1.01 |
INR | 124 | 5.17 | 0.011 | 1.45–18.4 | 76 | 1.45 | 0.840 | 0.04–53.1 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; CI, confidence interval; HE, hepatic encephalopathy; ICU, intensive care unit; INR, international normalized ratio; MELD, model for end-stage liver disease; OR, odds ratio; PSPG, portosystemic pressure gradient; PV, portal vein; RA, right atrium; TIPS, transjugular intrahepatic portosystemic shunt.
Excluding postorthotopic liver transplant mortality.